Mitochondrial diseases caused by toxic compound accumulation: from etiopathology to therapeutic approaches by Ivano Di Meo, Costanza Lamperti, Valeria Tiranti

Get full text

Effective AAV‐mediated gene therapy in a mouse model of ethylmalonic encephalopathy by Ivano Di Meo, Alberto Auricchio, Costanza Lamperti, Alberto Burlina, Carlo Viscomi, Massimo Zeviani

Get full text

Rapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesis by Gabriele Civiletto, Sukru Anil Dogan, Raffaele Cerutti, Gigliola Fagiolari, Maurizio Moggio, Costanza Lamperti, Cristiane Benincá, Carlo Viscomi, Massimo Zeviani

Get full text

A nonsense mutation of human XRCC4 is associated with adult‐onset progressive encephalocardiomyopathy by Leonardo Bee, Alessia Nasca, Alice Zanolini, Filippo Cendron, Pio d'Adamo, Rodolfo Costa, Costanza Lamperti, Lucia Celotti, Daniele Ghezzi, Massimo Zeviani

Get full text

Multifocal vitelliform lesions associated with mitochondrial retinopathy by Maurizio Battaglia Parodi, Alessio Antropoli, Lorenzo Bianco, Alessandro Arrigo, Sebastiano Del Fabbro, Paola Carrera, Ivana Spiga, Alessia Catania, Costanza Lamperti, Francesco Bandello, Ahmad Mansour

Get full text

Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial by Amel Karaa, Enrico Bertini, Valerio Carelli, Bruce Cohen, Gregory M. Ennes, Marni J. Falk, Amy Goldstein, Gráinne Gorman, Richard Haas, Michio Hirano, Thomas Klopstock, Mary Kay Koenig, Cornelia Kornblum, Costanza Lamperti, Anna Lehman, Nicola Longo, Maria Judit Molnar, Sumit Parikh, Han Phan, Robert D. S. Pitceathly, Russekk Saneto, Fernando Scaglia, Serenella Servidei, Mark Tarnopolsky, Antonio Toscano, Johan L. K. Van Hove, John Vissing, Jerry Vockley, Jeffrey S. Finman, Anthony Abbruscato, David A. Brown, Alana Sullivan, James A. Shiffer, Michelango Mancuso, on behalf of the MMPOWER-3 Trial Investigators

Get full text